Compare online weight-loss treatments
Explore treatment options, read provider reviews and compare costs, care access and commitments before choosing a program.
What would you like to compare?
Choose a company
Work through the care, costs and commitment behind a program.
Understand your options
Start with the treatment or program type you are researching.
Work out the cost
Separate the first payment from recurring charges using your quote.
Explore treatment programs
These guides explain what to check about the proposed product and the service behind it.
- GLP-1 programs
Understand the proposed product, evidence and care arrangement.
- Semaglutide programs
Identify the product, formulation and plan behind a semaglutide offer.
- Tirzepatide programs
Clarify the product, clinical purpose, refills and quoted cost.
- Weight-loss pill programs
Compare the named medicine, daily routine and complete package.
- Zepbound programs
Check the prescription, supply, access steps and full cost.
- Low-dose GLP-1 programs
Examine low-dose claims, the exact regimen and the quoted supply.
- Weight-loss programs for women
Prepare questions about individual circumstances and care responsibilities.
Find a provider review
Eight weight-loss programs, listed alphabetically. Read the service details and open questions for the program you are considering.
Make sense of the treatment questions
- Pills vs. injections for weight loss
Compare medication formats, routines and cost questions.
- Tirzepatide vs. semaglutide
Read how treatment differences inform a conversation with a prescriber.
- Compounded vs. brand-name GLP-1s
Read about product differences and questions to ask a program.
- Your first 30 days on a GLP-1
Explore questions about starting treatment, refills and follow-up.
Bring the details together
Compare programs
Choose programs and examine their recorded terms side by side.
Plan the payments
Enter a quote and see what is due upfront and over time.
Keep a shortlist record
Track the exact offer, care, budget, exit terms and unanswered questions.
Who may not be a good fit?
Eligibility depends on the specific drug and your medical history. For example, the current Zepbound label contraindicates use with a personal or family history of medullary thyroid carcinoma, MEN2, or a serious allergic reaction to tirzepatide or its ingredients. Discuss pregnancy, breastfeeding, other medicines, and planned procedures with your clinician.
Zepbound’s current warnings include pancreatitis, gallbladder disease, severe gastrointestinal reactions, dehydration-related kidney injury, hypoglycemia, and diabetic retinopathy complications in patients with type 2 diabetes. In January 2026, FDA requested removal of the suicidal-behavior warning after finding no increased risk in its review; the current Zepbound label records its removal in February 2026. Use the current label for the full safety information.
If needles are a concern, compare approved pills and injections with your clinician. Non-medication support may also fit your preferences, eligibility, or budget.
Safety passage checked: October 1, 2026.